Table 1. Clinical and serologic data of the 23 enrolled patients.
| Variables | w-COVID19 | i-COVID19 | CTRL | ANOVA | Kruskal-Wallis p-values |
|---|---|---|---|---|---|
| p-values* | |||||
| Number of patients (N = 23) | 9 | 6 | 8 | - | - |
| Median age, years (IQR) | 67 (IQR 44–83) | 70 (64–74) | 69 (51–77) | 0.702 | 0.7165 |
| Male, n (%) | 5 (55%) | 3 (50%) | 5 (62%) | - | - |
| Comorbidities, n (%) | 7 (78%) | 6 (100%) | 6 (75%) | - | - |
| Coinfections, n (%) | 1 (11%) | 4 (67%) | 0 (0%) | - | - |
| Colonization, n (%)‡ | 2 (22%) | 3 (50%) | 0 (0%) | - | - |
| E. Faecium, E. Faecalis | 2 E. Faecium, 1 E. Faecalis | ||||
| Antibiotic therapy at swab, n (%) | 5 (55%) | 3 (50%) | 3 (37%) | - | - |
| Lymphocytes, mm3 (IQR) | 1310 (1190–1480) | 810 (437–995) | 1400 (950–2070) | 0.201 | 0.1503 |
| C-reactive protein, mg/dl (IQR) | 3.25 (0.84–6.54) | 10.94 (3.09–12.53) | 1.45 (0.92–5.04) | 0.228 | 0.2711 |
| Ferritin, ng/ml (IQR) | 393 (169–616) | 960 (565–1121) | 289 (88–251) | 0.0153 | 0.04481 |
| Fibrinogen, mg/dl (IQR) | 529 (422–616) | 469 (346–600) | 470 (332–527) | 0.751 | 0.6684 |
| D-dimer, ng/ml (IQR) | 715 (265–1760) | 638 (350–865) | 760 (442–1845) | 0.309 | 0.7042 |
Table 1: w-COVID19: patients affected by COVID-19 hospitalized in ward for highly infectious diseases; i-COVID19: patients hospitalized in intensive care unit; CTRL: patients admitted in the same time period with nose-pharyngeal swab negative for SARS-CoV-2 infections; IQR: interquartile range.
*p-value, P <0.05 are considered statistically significant. ± Enterococcus faecium and Enterococcus faecalis.